SCHEMBL6873559

SCHEMBL6873559

COc1nc2ccccc2nc1I

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 4/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HRH4 Q9H3N8 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
HDAC6 Q9UBN7 1/20 0.45
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
POLB P06746 2/20 0.44
LMNA P02545 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 1/20 0.42
MAPT P10636 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474377 0.84 NQO2 (0.56) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL804981 0.76 TSHR (0.61) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL9091849 0.75 MAPT (0.62) NQO2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL14624137 0.74 NQO2 (0.52) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL4684319 0.74 KDM4E (0.58) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL12498159 0.74 NQO2 (0.47) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL2178510 0.74 TDP1 (0.58) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL5574299 0.74 NQO2 (0.47) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL22929108 0.74 NQO2 (0.47) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL18023044 0.74 TLR8 (0.49) NQO2MEN1KMT2AHRH4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011049908-A2 BISMACROKYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2011-04-28 WO disclosed